MYLAN 2047 MYLAN 2047 (Tacrolimus 5 mg)

Pill with imprint MYLAN 2047 MYLAN 2047 is Gray & Red, Capsule-shape and has been identified as Tacrolimus 5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tacrolimus is used in the treatment of nephrotic syndrome; organ transplant, rejection reversal; organ transplant, rejection prophylaxis; crohn's disease; graft-versus-host disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2047 MYLAN 2047

Save up to 80% off prescription medications

Click here for your free Discount Card

Tacrolimus

Imprint:

MYLAN 2047 MYLAN 2047

Strength:

5 mg

Color:

Gray & Red

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Calcineurin inhibitors

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

lactose anhydrous
ferrosoferric oxide
silicon dioxide
croscarmellose sodium
gelatin
hypromelloses
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
D&C Red No. 28
D&C Yellow No. 10
D&C Red No. 33
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
shellac
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
51079-0028	UDL Laboratories Inc.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer